QSAM begins patient enrolment for bone cancer therapy trial
QSAM Biosciences has commenced subject enrolment for its Phase I clinical trial of its therapy CycloSam (Samarium-153 DOTMP) to treat bone cancer, after activating its…
Latest Deals
-
Elligo Health ResearchMergers & Acquisitions $135M
-
Reify HealthCapital Raising $220M
-
CertaraMergers & Acquisitions $310M
-
ParexelMergers & Acquisitions $8.5BN
-
Elligo Health ResearchMergers & Acquisitions $135M
-
Reify HealthCapital Raising $220M
-
CertaraMergers & Acquisitions $310M
-
ParexelMergers & Acquisitions $8.5BN
Clinical Sector All Deal Activity by Value and Volume (Last 12 months)
Clinical Sector Overall Deal Activity by Region (Last 12 months)
Top Deals in Clinical Sector (Last 12 months)
| Acquirer/Investor | Issuer / Partner / Target | Deal Date | Value (US$m) |
|---|---|---|---|
| AstraZeneca | Alexion Pharmaceuticals | 12 Dec 2020 | 39,000.0 |
| The Carlyle Group ., The Blackstone Group , GIC Pvt , Hellman & Friedman | Medline Industries | 05 Jun 2021 | 34,000.0 |
| Thermo Fisher Scientific | PPD | 15 Apr 2021 | 20,900.0 |
| ICON | PRA Health Sciences | 24 Feb 2021 | 12,000.0 |
| Merck & | Acceleron Pharma | 29 Sep 2021 | 11,500.0 |
| Danaher | Aldevron | 17 Jun 2021 | 9,600.0 |
| Undisclosed Bidder | Parexel International | 20 Apr 2021 | 9,000.0 |
| EQT Partners AB, Goldman Sachs Asset Management | Parexel International | 02 Jul 2021 | 8,500.0 |
| Agnafit Bidco | Swedish Orphan Biovitrum | 02 Sep 2021 | 8,047.6 |
| Jazz Pharmaceuticals | GW Pharmaceuticals | 03 Feb 2021 | 7,200.0 |
Top Clinical Sector Advisors (2020 Vs. 2019)
Top Financial Advisors – All Deals
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Centerview Partners | 1 | 9 |
| Morgan Stanley | 2 | 1 |
| The Goldman Sachs Group | 3 | 4 |
| Bank of America Corp | 4 | 10 |
| JPMorgan Chase & Co | 5 | 20 |
| Evercore | 6 | 3 |
| Lazard | 7 | 18 |
| Ondra | 8 | 67 |
| Cowen | 9 | 19 |
| J.P. Morgan Securities | 10 | 2 |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Jefferies | 1 | 8 |
| The Goldman Sachs Group | 2 | 2 |
| Cowen | 3 | 33 |
| Centerview Partners | 4 | 4 |
| Bank of America Corp | 5 | 9 |
| SVB Financial Group | 6 | 12 |
| Morgan Stanley | 7 | 1 |
| Evercore | 8 | 7 |
| Rothschild & Co SCA | 9 | 5 |
| Barclays Plc | 10 | 23 |
Top Legal Advisors – All Deals
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Wachtell, Lipton, Rosen & Katz | 1 | 3 |
| Fried, Frank, Harris, Shriver & Jacobson | 2 | 19 |
| Goodwin Procter | 3 | 20 |
| Freshfields Bruckhaus Deringer | 4 | 16 |
| Allen & Overy | 5 | 62 |
| Latham & Watkins | 6 | 21 |
| Davies Ward Phillips & Vineberg | 7 | 53 |
| Simmons & Simmons | 8 | 173 |
| Sullivan & Cromwell | 9 | 15 |
| Davis Polk & Wardwell | 10 | 2 |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Goodwin Procter | 1 | 2 |
| Wilson Sonsini Goodrich & Rosati | 2 | 23 |
| Latham & Watkins | 3 | 1 |
| Cooley | 4 | 5 |
| Ropes & Gray | 5 | 7 |
| Kirkland & Ellis | 6 | 4 |
| Baker & McKenzie | 7 | 12 |
| Morgan, Lewis & Bockius | 8 | 13 |
| Jones Day | 9 | 3 |
| Dechert | 10 | 54 |
Clinical Sector Mergers & Acquisitions Deal Activity by Value and Volume (Last 12 months)
Clinical Sector Mergers & Acquisitions by Region (Last 12 months)
Top Mergers & Acquisitions in Clinical Sector (Last 12 months)
| Acquirer/Investor | Issuer / Partner / Target | Deal Date | Value (US$m) | AstraZeneca | Alexion Pharmaceuticals | 12 Dec 2020 | 39,000.0 | Thermo Fisher Scientific | PPD | 15 Apr 2021 | 20,900.0 | ICON | PRA Health Sciences | 24 Feb 2021 | 12,000.0 | Merck & | Acceleron Pharma | 29 Sep 2021 | 11,500.0 | Danaher | Aldevron | 17 Jun 2021 | 9,600.0 | Agnafit Bidco | Swedish Orphan Biovitrum | 02 Sep 2021 | 8,047.6 | Jazz Pharmaceuticals | GW Pharmaceuticals | 03 Feb 2021 | 7,200.0 | Humana | Kindred Healthcare | 27 Apr 2021 | 5,700.0 | PerkinElmer | Biolegend | 26 Jul 2021 | 5,250.0 | CBPO Holdings | China Biologic Products Holdings | 19 Nov 2020 | 4,760.0 |
|---|
Top Clinical Sector Advisors (2020 Vs. 2019)
Top Financial Advisors - Mergers & Acquisitions Deals
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Centerview Partners | 1 | 9 |
| Morgan Stanley | 2 | 1 |
| The Goldman Sachs Group | 3 | 4 |
| Bank of America Corp | 4 | 12 |
| JPMorgan Chase & Co | 5 | 20 |
| Evercore | 6 | 3 |
| Lazard | 7 | 15 |
| Ondra | 8 | 49 |
| Cowen | 9 | 17 |
| Mizuho Financial Group | 10 | N/A |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Centerview Partners | 1 | 4 |
| The Goldman Sachs Group | 2 | 2 |
| Bank of America Corp | 3 | 6 |
| Jefferies | 4 | 5 |
| Lazard | 5 | 3 |
| Morgan Stanley | 6 | 1 |
| JPMorgan Chase & Co | 7 | 24 |
| Evercore | 8 | 8 |
| Cowen | 9 | 35 |
| Barclays Plc | 10 | 23 |
Top Legal Advisors - Mergers & Acquisitions Deals
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Wachtell, Lipton, Rosen & Katz | 1 | 3 |
| Fried, Frank, Harris, Shriver & Jacobson | 2 | 18 |
| Goodwin Procter | 3 | 19 |
| Freshfields Bruckhaus Deringer | 4 | 20 |
| Allen & Overy | 5 | 65 |
| Davies Ward Phillips & Vineberg | 6 | 45 |
| Simmons & Simmons | 7 | 126 |
| Sullivan & Cromwell | 8 | 15 |
| Latham & Watkins | 9 | 22 |
| Davis Polk & Wardwell | 10 | 2 |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Goodwin Procter | 1 | 1 |
| Cooley | 2 | 3 |
| Morgan, Lewis & Bockius | 3 | 11 |
| Latham & Watkins | 4 | 2 |
| Wilson Sonsini Goodrich & Rosati | 5 | 16 |
| White & Case | 6 | 23 |
| Skadden, Arps, Slate, Meagher & Flom & Affiliates | 7 | 4 |
| Ropes & Gray | 8 | 15 |
| Gibson, Dunn & Crutcher | 9 | 22 |
| Kirkland & Ellis | 10 | 6 |
Clinical Sector Private Equity Deal Activity by Value and Volume (Last 12 months)
Clinical Sector Private Equity Deals by Region (Last 12 months)
Top Private Equity Deals in Clinical Sector (Last 12 months)
| Acquirer/Investor | Issuer / Partner / Target | Deal Date | Value (US$m) | The Carlyle Group ., The Blackstone Group , GIC Pvt , Hellman & Friedman | Medline Industries | 05 Jun 2021 | 34,000.0 | Undisclosed Bidder | Parexel International | 20 Apr 2021 | 9,000.0 | EQT Partners AB, Goldman Sachs Asset Management | Parexel International | 02 Jul 2021 | 8,500.0 | Permira Advisers | LivaNova | 04 Mar 2021 | 3,700.0 | CVC Capital Partners Fund VII, Avista Capital Partners (Avista Capital Holdings, ) | Cooper Consumer Health | 12 Mar 2021 | 2,600.0 | EQT IX Fund | Recipharm | 14 Dec 2020 | 2,116.9 | Nordic Capital | Advanz Pharma | 27 Jan 2021 | 1,920.1 | Partners Group | Pharmathen | 19 Jul 2021 | 1,888.7 | Altaris Capital Partners | Generic Rx Pharma Business | 01 Mar 2021 | 1,550.0 | CBC Group | Hugel | 27 Aug 2021 | 1,500.0 |
|---|
Top Clinical Sector Advisors (2020 Vs. 2019)
Top Financial Advisors – Private Equity Deals
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Rothschild & Co SCA | 1 | 1 |
| Deloitte Touche Tohmatsu | 2 | 23 |
| Carnegie Holding AB | 3 | N/A |
| Goldman Sachs International | 4 | N/A |
| Jefferies International | 5 | N/A |
| Ernst & Young Global | 6 | 31 |
| PricewaterhouseCoopers International | 7 | 2 |
| UBS Group AG | 8 | 3 |
| Jefferies | 9 | 49 |
| Evercore | 10 | 15 |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Jefferies | 1 | 50 |
| SVB Financial Group | 2 | 36 |
| Rothschild & Co SCA | 3 | 2 |
| Carnegie Holding AB | 4 | N/A |
| Cowen | 5 | N/A |
| Deloitte Touche Tohmatsu | 6 | 8 |
| Evercore | 7 | 7 |
| Barclays Plc | 8 | 15 |
| Van Lanschot Kempen NV | 9 | N/A |
| Ernst & Young Global | 10 | 10 |
Top Legal Advisors – Private Equity Deals
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Ropes & Gray | 1 | 17 |
| Latham & Watkins | 2 | 10 |
| Uria Menendez Abogados S | 3 | N/A |
| Goodwin Procter | 4 | 28 |
| Clifford Chance | 5 | 41 |
| Roschier Attorneys | 6 | 38 |
| Setterwalls Advokatbyra AB | 7 | N/A |
| Allen & Overy | 8 | 56 |
| Linklaters | 9 | 5 |
| Ashurst | 10 | 7 |
| Advisor Name | 2020 Rank | 2019 Rank |
|---|---|---|
| Latham & Watkins | 1 | 1 |
| Goodwin Procter | 2 | 36 |
| Ropes & Gray | 3 | 3 |
| Uria Menendez Abogados S | 4 | N/A |
| Baker & McKenzie | 5 | N/A |
| Kirkland & Ellis | 6 | 2 |
| DLA Piper | 7 | N/A |
| Sidley Austin | 8 | 19 |
| Dechert | 9 | 35 |
| Paul, Weiss, Rifkind, Wharton & Garrison | 10 | 16 |
Clinical Sector Venture Financing Deal Activity by Value and Volume (Last 12 months)
Clinical Sector Venture Financing Deals by Region (Last 12 months)
Top Venture Financing Deals in Clinical Sector (Last 12 months)
| Acquirer/Investor | Issuer / Partner / Target | Deal Date | Value (US$m) | GV Management , New Enterprise Associates , 8VC, ARCH Venture Partners | National Resilience | 23 Nov 2020 | 750.0 | Temasek Holdings (Private) , GL Ventures, Lilly Asia ventures | Suzhou Abogen Biosciences | 19 Aug 2021 | 700.0 | Itochu Technology Ventures, ., Invus Group , Emerson Collective , Vertex Ventures HC, EcoR1 Capital , F2 Ventures Limited, Matrix Capital Management Fund , Surveyor Capital , SoftBank Vision Fund , Redmile Group , Fidelity Management & Research Company, EDBI Pte , Samsara BioCapital , MPM Capital | ElevateBio | 15 Mar 2021 | 525.0 | SignalFire Management Services, , Radcliff Group, Baupost Group, FirstMark Capital , Altimeter Capital Management , TQ Ventures , General Catalyst Partners , BoxGroup, ShawSpring Partners, , Dragoneer Investment Group , Torch Capital, 776 Fund Management | Ro-co | 23 Mar 2021 | 500.0 | Andreessen Horowitz , Nextech Invest , Casdin Capital , ARCH Venture Partners , Section 32, Arboretum Ventures , GV Management | EQRx | 11 Jan 2021 | 500.0 | Canada Pension Plan Investment Board, Fidelity Management & Research Company, T Rowe Price Associates , Flagship Pioneering , BlackRock , Federated Hermes , Invus | Laronde | 30 Aug 2021 | 440.0 | Sino Biopharmaceutical , 5Y Capital, Orbimed Advisors , Sequoia Capital Operations , RRJ Capital | XtalPi | 11 Aug 2021 | 400.0 | Altitude Life Science Ventures, ARCH Venture Partners , F-Prime , Invus Group , Alexandria Venture Investments, Polaris Partners , Waycross Ventures ., Mubadala Capital, Surveyor Capital , Logos Global Management , SoftBank Vision Fund II, Catalio Capital Management , Newpath Management , re.Mind Capital | Neumora Therapeutics | 07 Oct 2021 | 400.0 | Temasek Holdings (Private) , Two Sigma Ventures , GV Management , Alexandria Venture Investments, Foresite Capital Management , SoftBank Investment Advisors, Third Rock Ventures , BlackRock , T Rowe Price Associates , Andreessen Horowitz , ARCH Venture Partners , Canada Pension Plan Investment Board, HOF Capital, Casdin Capital | Insitro | 15 Mar 2021 | 400.0 | Premji Invest, Orbimed Advisors , Population Health Partners , GV Management , Foresite Capital Management , Federated Hermes , Mithril Capital Management , RA Capital Management , Redmile Group , ArrowMark Partners, Polaris Partners , Adimab , Omega Fund Management , Fidelity Management & Research | Adagio Therapeutics | 19 Apr 2021 | 336.0 |
|---|
All markets data shared in the dashboard is copyright of GlobalData PLC and is subject to the GlobalData Terms & Conditions. Content in the dashboard should not be viewed as a recommendation and should not be relied upon to make investment decisions. We make every effort to ensure our content is accurate and to correct mistakes as soon as possible. If you spot an error please email editorialenquiries@globaldata.com. Further information about our editorial standards and complaints procedure is available here. GlobalData is not responsible for the use of any content outside the scope of the GlobalData Terms & Conditions.
Latest News
View More
Revelation Biosciences begins Phase IIb trial of H3N2 influenza therapy
Revelation Biosciences has commenced a Phase IIb study of its intranasal drop solution, REVTx-99, in healthy individuals to prevent H3N2 influenza (influenza A). The solution…
Sobi and Selecta Biosciences complete enrolment for gout therapy trial
Swedish Orphan Biovitrum (Sobi) and Selecta Biosciences have completed the enrolment of participants for the DISSOLVE I study to assess…
GreenLight and IAVI partner for Phase I trial of Covid-19 vaccine in Africa
GreenLight Biosciences has collaborated with non-profit scientific research organisation International AIDS Vaccine Initiative (IAVI) for a Covid-19 vaccine trial in…
Longeveron to explore cell-based therapy in trial of older and frail subjects
Longeveron has signed a sponsored clinical research agreement with Japan’s National Center for Geriatrics and Gerontology (NCGG) and Juntendo University…
Axial Therapeutics begins dosing in Phase IIb autism therapy trial
Axial Therapeutics has dosed the first participants in an international Phase IIb clinical trial of a gut-targeted molecular therapy, AB-2004,…
Company A-Z
View More
VaLea Clinical Trials
Patient-Centric Services for In-Home or Alternate-Site Clinical Trials Settings
